The Latest in Managing Disability Due to Mental Illness

Date: Tuesday, October 18, 2022 

In this webinar, Mark Faiz will examine the components that pharmacogenomics testing for mental illness must have for the testing to be effective.

We will explore the process that is necessary for case managers to follow to achieve good Return to Work results for mental illness patients.

The results that leading case managers, assisted by second generation pharmacogenomics, are achieving in reducing duration of mental illness disability will also be discussed.

Speaker: Mark Faiz, CEO, Personalized Prescribing Inc.

Sponsored By: